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Christopher Zarins provided me with growth and chal-
lenge during my fellowship at the University of Chicago.
Drs James Yao and John Bergan contributed to my devel-
opment during that same year in Chicago. I have had the
fulfilling experience of practicing with many talented part-
ners who have enriched my surgical career. These friends
and mentors have been instrumental in my professional
life, and for that I am exceedingly grateful. Most impor-
tant, however, has been my family. My wife, Rosanne, has
given me unwavering support, love, and understanding.
She has been my compass. She and our two sons, Brian
and Shaun, have given me fulfillment that professional
success alone could never have provided.
Vascular surgery as a specialty is facing many challenges
today. A number of these were thoughtfully examined by
Dr Greg Sicard, our past-president, in his address last year.
When preparing for my address today, I strongly felt that
further consideration of some of these issues would be
appropriate. As we enter this new millennium, I would like
to consider some of these challenges and reflect on the
impact on our patients as well as the role of our organiza-
tion in meeting and solving them. The evolution of our
society and its relationship to other vascular societies should
be reviewed to put our role in some perspective.
The organization of societies to support vascular
surgery dates back to the establishment of two national
societies. The Society for Vascular Surgery first met in
1947, and the International Society for Cardiovascular
Surgery (ISCVS) (North American Chapter) first met in
1952. As vascular surgery grew, so did these organiza-
tions, providing a national forum for the discussion of the
surgical treatment of vascular disease. As our specialty con-
tinued to evolve and the number of surgeons treating vas-
cular disease increased, local and regional societies began
to formally organize. The MWVSS was among the early
regional developments. There are currently five major
regional societies. The New England Society for Vascular
Surgery (NESVS) was first established in 1973. It was fol-
lowed by the MWVSS (1977), the Southern Association
for Vascular Surgery (SAVS) (1977), the Eastern Vascular
It has been a great privilege and honor for me to serve
as president of the Midwestern Vascular Surgical Society
(MWVSS) over the past year. I remember attending the
very first annual meeting in Chicago in 1977 as a resident.
I was impressed with the prominent leaders of our spe-
cialty who attended and with the science that was pre-
sented. Both the Society and I have grown over the last 23
years, and I am extremely grateful to have had the oppor-
tunity to serve as your leader.
In preparation for this opportunity to speak to you
this morning, I have spent time contemplating the past as
well as the challenges of our future. Although this is always
a valuable exercise, its seems especially appropriate as we
enter the new millennium, a time of unprecedented
change. In examining my past, I recall some individuals
who have played important roles in my life and have made
significant contributions to whatever success I have
achieved. I would like to recognize some of them. My par-
ents instilled in me the importance of a work ethic and
academic achievement and taught me important values
about honesty, genuineness, and caring. My father, a suc-
cessful academic radiologist, served as a role model for my
professional achievement. Dr William Fry unveiled the
excitement, demands, and challenges of the surgical treat-
ment of disease for me when I was a medical student. Both
he and Dr James Stanley fostered my interest in vascular
surgery during my residency, and Jim served as a talented
and unselfish mentor during my early academic career. Dr
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Society (EVS) (1984), and the Western Vascular Society
(WVS) (1986). Active and senior membership in these
societies currently includes 207 (NESVS), 354 (SAVS),
497 (EVS), and 162 (WVS).
The MWVSS remains strong with 377 active and senior
members. Each society varies somewhat in its membership
requirements and objectives. Generally, they have estab-
lished goals similar to the MWVSS. It is noteworthy that
there are many local and smaller regional societies that fall
within the geographic boundaries of the major regional
societies. These may include several states (eg, Rocky
Mountain Vascular Society), one state (eg, Michigan
Vascular Society), or a portion of one state (eg, Cleveland
Vascular Society). There has not been any formal organiza-
tion or representation of these smaller societies at either the
regional or national level. They do represent true grassroot
organizations of our specialty, however.
The MWVSS began with discussions among Drs John
Bergan, Emerick Szilagyi, and John Pfeifer in October
1976. The founding meeting was held in March 1977.
The objectives of the Society were established to be (1)
the advancement of the science and art of peripheral vas-
cular surgery and (2) the maintenance of high standards in
the practice of peripheral vascular surgery. The first annual
meeting was held in Chicago in September 1977. The
Charles C. Guthrie Award was established in 1981 to fur-
ther bolster the first objective of the Society. This award
was to be given yearly to a resident or fellow based on out-
standing basic or clinical research related to vascular dis-
ease. The Society has obviously grown and flourished since
those early days. Many of our members have gone on to
make significant contributions nationally, including nine
who have served as presidents of one of our national soci-
eties. We remain a strong Society. The annual meeting
attracts excellent clinical science every year. We must,
however, continue to grow and ensure that all qualified
surgeons providing vascular care are included in our 
membership ranks. We must also actively participate in dis-
cussions regarding our second goal. Some recent organiz-
ational changes will facilitate that.
Our Society has had indirect input to our national
organizations in the past. An individual representing
regional societies has held a seat on the Executive Council
of the ISCVS. For the last 18 months, the MWVSS had an
appointed representative as a member-at-large seated on
the executive council of the ISCVS. As you are all aware,
the ISCVS has recently become the American Association
for Vascular Surgery (AAVS). Reorganization of that soci-
ety is currently in progress. Although the details have not
been finalized, it appears that the MWVSS will have a per-
manent seat on the Executive Council along with the four
other major regional vascular societies. Five other societies
(the American Venous Forum, the Peripheral Vascular
Surgery Society, the Society for Clinical Vascular Surgery,
the Canadian Vascular Society, and the International
Society for Endovascular Specialists) will also have seats.
Although these societies have some differences in their
makeup, this reorganization will allow direct input and
dissemination of information vital to our interests. These
changes will support a more organized and efficient effort
to enhance our specialty and address specific issues as they
arise. In addition, this reorganization will allow individual
societies to collectively benefit from pooled resources
enabling the accomplishment of projects that could not
otherwise be supported. Web development is a prime
example of such a project. Both extensive patient educa-
tion efforts and dissemination of organizational informa-
tion can be accomplished more easily and less expensively
with such combined effort. This is an extremely positive
change from which we will all benefit. This new opportu-
nity for the Society will allow us to collectively make more
meaningful contributions to support our specialty.
A number of critical issues and challenges face our spe-
cialty today. Dr Sicard examined a number of these issues
in his address last year.1 He explored the critical issues of
reimbursement, competition, training, and research fund-
ing. These are all matters of ongoing importance, and the
MWVSS must continue to contribute to discussions and
the search for solutions. The complex and challenging
issues surrounding the American Board of Surgery are
being addressed at a national level. I would like to discuss
some issues that may not have received as much attention
as a result of the pressing controversies surrounding some
of these other problems.
As vascular surgeons, we provide care for an aging pop-
ulation. Not only is the population of the United States
growing, but the number of those older than 65 years con-
tinues to increase substantially with the aging of the baby
boom generation. It is projected that by the year 2008,
38.4 million or 12.6% of our nation’s population will be in
that age group.2 By the year 2050, the proportion of
Americans older than 65 will approach 22% or nearly one
in four. In addition, the health-related expenditures of our
nation continue to grow and now represent 14.3% of our
nation’s gross domestic product. It is projected that by
2008, this will climb to 16.2%.2 These two factors will have
a substantial impact on the affordability of health care in
the future. The cost of prescription drugs has received the
most recent visibility but is, in part, a surrogate for the cost
of medical progress. The total expense for prescription
drugs was $37.7 billion in 1990. This value is projected to
grow to $243 billion by 2008.3 As our nation ages and
more patients present with vascular disease and as technol-
ogy continues to expand, similar trends may be seen in the
treatment of vascular disease. The current developments in
the treatment of abdominal aortic aneurysms exemplify
some of these changes. The balance of risk, clinical benefit,
and cost benefit will become increasingly important.
Appropriate application of new techniques will become
similarly crucial. If we do not responsibly oversee these
developments, someone else will. As new technology has
become available in the past, restraint in its use has not
always been well embraced. As better percutaneous tech-
niques become available and other specialties become
involved with applications of the techniques, potential
overutilization will similarly have an impact on the expense
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of health care. We as vascular surgeons should be leaders in
appropriate applications of these techniques.
The evolution of the treatment of superficial femoral
artery (SFA) disease in the setting of intermittent claudi-
cation is an example of a clinical situation with potential
for such overutilization. The natural history of intermit-
tent claudication is well documented. Although it is now
recognized as less benign than once thought, a conserva-
tive approach to this condition has long been understood
to be desirable. Lower extremity bypass procedures with
saphenous vein were first described by Kunlin in 19494
and were the only other option for a number of years. The
development of prosthetic materials and refinement of
surgical techniques with improved instrumentation and
suture material as well as in situ methods added to the sur-
geon’s capabilities. Profundaplasty gained some recogni-
tion as an alternative. Dotter and Judkins5 first introduced
the concept of arterial dilatation in 1964. Gruntzig and
Kumpe6 described the use of balloon catheters for percu-
taneous transluminal angioplasty (PTA) in 1979, and the
evolution of interventional techniques for the treatment of
intermittent claudication began.
Aggressive use of PTA resulted in the understanding
that this technique had little value in the SFA except for
isolated stenoses in carefully selected patients.7 With the
subsequent development of laser-assisted angioplasty and
atherectomy, a great deal of enthusiasm was again stimu-
lated but with the same ultimate conclusions.8 Now, we
are faced with the development of stenting devices that
may have an impact on long-term patency rates in the
SFA.9 This potential benefit has yet to be substantiated in
the literature, however. Despite enthusiasm for the aggres-
sive interventional treatment of SFA disease in the setting
of claudication, the number of patients who are truly dis-
abled and have desirable anatomy for PTA remains rela-
tively small. Practitioners from other specialties are
assaulting the SFA without the full understanding of the
natural history of these lesions and without necessarily
exhausting conservative measures first.
I have personally seen several patients in our practice
who have undergone SFA angioplasty with stent deploy-
ment throughout the entire length of the vessel at other
institutions. This approach is one based on enthusiasm
and reimbursement opportunity without adequate judg-
ment or reflection on the long-term impact on the patient.
Unfortunately, the promise of potential short-term results
encourages the patient to undergo such procedures. I
remember a pleasant 77-year-old patient of mine who pre-
sented with moderate claudication that he considered
troublesome. We spent considerable time over a number
of months discussing the pros and cons of interventional
therapy. After exhausting possible conservative measures,
we finally agreed to proceed with arteriography. This study
demonstrated multiple segmental stenoses of the SFA with
severe infrapopliteal occlusive disease. He was clearly not a
surgical candidate in the absence of limb-threatening
ischemia. He was satisfied with the conclusion that ongo-
ing conservative management was appropriate. I saw him
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1 year later, essentially unchanged clinically. In the
interim, however, he had been seen in another state for a
second opinion. At that institution, he underwent cerebral
arteriography, renal arteriography, aortography, and lower
extremity arteriography. Subsequent extensive SFA angio-
plasty with stent placement was performed. He experi-
enced some improvement for several months but then
returned to his previous state. That outcome was pre-
dictable, yet he was led to believe otherwise. This specific
example demonstrates the potential for substantial
overutilization of percutaneous procedures. This patient
was fortunate that his extremity was not jeopardized.
As technology for the treatment of vascular disease
expands, we must remain vigilant. Critical scientific out-
comes assessment before widespread application of new
techniques is essential. The maintenance of high standards
in the treatment of peripheral vascular disease is paramount.
This can occur at various levels. Scientifically sound clinical
science must continue to receive visibility at our regional
and national meetings. Appropriate guidelines or standards
can and have been developed by our national societies.10 In
our current environment, this development would ideally
occur in conjunction with other societies representing the
other specialties treating vascular disease. As leaders in the
treatment of vascular disease, we must assume a leadership
role in our own institutions by providing the wisdom nec-
essary to ensure appropriate application of these invasive
techniques. Hospital credentialling committees are now
being faced with requests for peripheral interventional priv-
ileges from additional subspecialists and should look to vas-
cular surgeons for guidance. Recommendations must be
based on valid clinical science with the use of outcomes
assessment. It is at this level that our input will be most
needed. As has been demonstrated in the past, if we do not
set the standards and ensure local compliance, someone will
soon step forward to assist us in this task. Many examples
would suggest that the latter is a suboptimal solution.
Recently, employers have become organized to have an
impact on more rapid change in the health care system dri-
ven by quality measures that they define. They are chal-
lenging our ability to do this ourselves.
We are now facing a time of unprecedented pressures,
changes, and conflicts. Reimbursement for our services is
diminishing at a time when various compliance programs
and other forces increase the overhead of practice.
Interventional techniques may replace some of our time-
tested surgical procedures in the near future. Nonsurgeons
will perform many of these procedures. The tendency to
treat existing lesions without the understanding of natural
history is dangerous but increasingly prevalent. Our work
hours have gradually increased at an unrelenting pace such
that we have focused on efficiency and have less time to
spend with our patients. Information is at the fingertips of
all of our patients who are computer literate and can use
the Internet. If the patients are not computer literate, their
children are. I am amazed at the number of my elderly
patients who come to the office with printouts from Web
pages regarding the newest cutting edge techniques such
as aortic stent grafting. Unfortunately, the information is
frequently incomplete or incorrect. This presents a setting
where more time may be necessary to have a meaningful
interchange with the patient regarding his disease. It is no
wonder that patients feel confused and unimportant. The
patient’s perception of this scenario should be of great
concern. We need to examine how we are practicing today.
For a multitude of reasons the public holds us in less
esteem than in the past. A 1996 Gallup survey reported
that only 15% of those surveyed had a high opinion of the
medical profession, down from 40% in 1983.11 Data con-
cerning our specialty per se are not available. In general,
surgeons are held in higher esteem. However, the message
is clear. Our patients feel that they are not being served
well. We are in part responsible. We have become focused
on technical procedures more than interpersonal relation-
ships with our patients. We have at times become focused
on the problems of our practices and ourselves rather than
our patient’s problems. To better serve our patients, we
need to better understand their expectations.
Patients expect that we will abide by four principles as we
diagnose and treat them.12 Reflection on these principles
may assist us in setting certain priorities as we sort through
these challenges that face us. The first two principles include
beneficence and nonmaleficence. These can be traced back to
the Hippocratic oath that we have all professed. In today’s
framework, this means that patients demand that we offer
therapy that has been clinically tested and has predictable and
beneficial outcomes. Patients also expect that these interven-
tions will be performed appropriately and skillfully without
exposing them to unnecessary or inappropriate risks.
The third principle is that of autonomy. Patients reserve
the right to decide what is best for themselves after we have
informed them of their options. While this seems to be read-
ily evident, it is a significant change from patient expecta-
tions a generation ago. In addition, the decision that the
patient makes is based on the education that he or she
received from the surgeon and other sources. The presenta-
tion of factual information is critical in the doctor-patient
relationship. The information must be accurate and objec-
tive, yet it must be delivered in an unbiased manner that the
patient can understand. New therapeutic modalities are pre-
senting new challenges for this education process. Stent-
grafting for abdominal aortic aneurysms is an excellent
example. Some differences between open and endovascular
aneurysm repair are more subtle than are first obvious.
Certainly, the less invasive technique may appear intuitively
advantageous. However, there presently appears to be no
significant difference in mortality. In addition, the long-term
results are certainly better defined with the open surgical
technique. The need for long-term follow-up also enters
into the equation. As a result, subtle differences in the pre-
sentation of this information can easily sway the patient’s
decision-making process. A balanced presentation of short-
term and long-term risks and benefits is critical, yet the
patients may not be able to hear their options in a balanced
fashion. This can become a very time intensive process fur-
ther complicating the doctor-patient relationship.
The last principle is justice. This implies that we, as
physicians, will participate in the fair distribution of treat-
ment options and services. This principle is becoming
more challenging as the cost of medical care continues to
escalate. Our participation can be at many levels. The most
basic, however, is to ensure appropriate application of
technology in our own practices and the hospitals in which
we practice. In this way, we can continue to support the
maintenance of high standards in the practice of peripheral
vascular surgery. Our patients expect nothing less of us.
As we enter this new millennium, diverse obstacles and
opportunities await vascular surgery as a specialty and vas-
cular surgeons as individuals. We must not only use the
resources and strategies that are available now, but also cre-
ate new solutions if we are going to survive and thrive as a
specialty to provide the high-quality care that our patients
have come to expect. The MWVSS will continue to serve as
an effective regional resource with members capable of sub-
stantial accomplishments. These accomplishments may be
at the national level with our new alignment with the AAVS,
at the regional level with MWVSS work, or at the local level
with regional or national societal support. Our challenge
will be to maximize the opportunities that are presented to
us as an organization and develop methods to support the
individual vascular surgeon, our members, facing the chal-
lenges of health care today. There is immense talent within
this society, and I know that we are capable of responding
to the challenges ahead.
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